Edison Pharmaceuticals' Unattributed Round

Edison Pharmaceuticals raised a round of funding on March 27, 2014.

Edison Pharmaceuticals is developing treatments for inherited mitochondrial disease - a genetic disorder that share as a common link defects in how cells make and regulate energy. The company has buil…

Articles about Edison Pharmaceuticals' Unattributed Round: